temazepam 15 mg
INDICATIONS AND USAGE Temazepam is indicated for the short-term treatment of insomnia (generally 7 - 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that temazepam should be used for short periods of time (7 - 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.
aphena pharma solutions - tennessee, llc
Related Pills
temazepam 15 mg
aphena pharma solutions - tennessee, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Repackaged by Aphena Pharma Solutions - TN. See Repackaging Information for available configurations.
TEMAZEPAM capsules USP 15 mg — Each #3 capsule with green opaque cap and white opaque body, imprinted with 076 in black ink on both cap and body contains 15 mg of
TEMAZEPAM, USP. capsules are supplied in bottles of 100 (NDC 0228-2076-10) and 500 (NDC 0228-2076-50). 30 mg — Each #3 capsule with white opaque cap and body, imprinted with 077 in black ink on both cap and body contains 30 mg of
TEMAZEPAM, USP. capsules are supplied in bottles of 100 (NDC 0228 2077-10) and 500 (NDC 0228-2077-50). Dispense in a tight, light-resistant container as defined in the USP. Store at 25(C (77(F); excursions permitted to 15( to 30(C (59( to 86(F). Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue Elizabeth, NJ 07207 USA 40-8787 Revised –January 2009
More pills like CAPSULE R 076